Biological Testing Facility (X01 Clinical Trial Not Allowed)
ID: 347844Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347844

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-192.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the X01 Resource Access Award to support research aimed at advancing contraceptive development. This initiative, managed by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), allows researchers to request services from the Biological Testing Facility for preclinical studies, with a focus on developing safe, non-hormonal contraceptive methods. The program is designed to facilitate the submission of Investigational New Drug (IND) applications and is open to a wide range of eligible applicants, including educational institutions, nonprofits, and government entities, both domestic and foreign. Applications are accepted on a rolling basis, with key deadlines including May 30, 2023; January 2, 2024; and subsequent dates through 2025. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-192.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-192-Full-Announcement.html
    PAR-23-192.html
    The Department of Health and Human Services announces a funding opportunity through the National Institutes of Health (NIH) for the X01 Resource Access Award, aimed at advancing contraceptive research. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) manages this initiative, focusing on developing safe, non-hormonal contraception methods. Researchers can request support services from the NICHD's Biological Testing Facility for preclinical studies, with a long-term goal of facilitating Investigational New Drug (IND) applications. Applications are accepted regardless of existing NIH funding, although priority may be given to current NIH-supported projects. Key deadlines include application due dates of May 30, 2023; January 2, 2024; and subsequent dates through 2025. This grant does not provide funds directly but facilitates access to resources necessary for significant advancements in contraceptive research. Eligibility includes various educational institutions, nonprofits, and government entities, both domestic and foreign. The application process requires detailed research proposals, adherence to submission guidelines, and completion of necessary registrations with federal systems. The goal is to support innovative contraceptive solutions that align with current public health needs.
    Similar Opportunities
    Biological Testing Facility (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Biological Testing Facility (X01 Clinical Trial Not Allowed)" aimed at supporting research in the development of non-hormonal contraceptive methods. This grant allows investigators to access the Biological Testing Facility (BTF) for preclinical studies and Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies, with a focus on advancing contraceptive development to address unintended pregnancies in the U.S. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofits, and foreign entities, with applications due by May 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-192.html.
    Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is offering a funding opportunity titled "Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)." This initiative aims to support the development of non-hormonal contraceptives and reproductive health products by providing access to a state-of-the-art facility that offers preclinical services, including protein generation, high throughput screening, and drug metabolism studies. The program is designed to facilitate research that leads to safe and effective reproductive health therapies, with a focus on innovation and scientific merit in project proposals. Applications are open from September 3, 2023, with deadlines on October 3 and April 3 annually until 2026. Eligible applicants include various organizations such as higher education institutions, non-profits, and tribal governments. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03), which supports small clinical trials focused on basic experimental studies involving human participants. This funding opportunity aims to enhance understanding of fundamental phenomena without immediate application towards products or processes, aligning with the NICHD's mission in human development, behavior, and health. Grants are available for up to $50,000 in direct costs per year, with a maximum project duration of two years, and applications must be submitted by January 7, 2025. Interested applicants can find more information and application details at the NIH website or contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance.
    Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)" aimed at supporting the development of innovative Multipurpose Prevention Technologies (MPTs) that prevent HIV, sexually transmitted infections (STIs), and pregnancy. The initiative encourages applications that focus on both event-driven and long-acting MPTs, integrating user-desired features to enhance adoption and adherence, while also promoting biobehavioral research alongside pharmacokinetic and pharmacodynamic studies. This funding opportunity is open to a wide range of eligible applicants, including higher education institutions, nonprofits, and various community organizations, with applications due by December 7, 2024. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-180.html.
    NICHD Small Research Grant Program (R03 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03 Clinical Trial Required) to support clinical trials that align with the mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This grant program is designed to fund small research projects with a maximum budget of $50,000 in direct costs per year, for a duration of up to two years, focusing on areas such as human development, childhood development, and rehabilitation medicine. Eligible applicants include a diverse range of organizations, including higher education institutions, nonprofits, for-profits, and tribal governments, with all applications required to propose clinical trials and adhere to NIH submission guidelines. Interested parties should note that the application deadline is January 7, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further inquiries. More information can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PA-21-221.html.
    NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)" to support the development and dissemination of vital bioinformatics resources related to embryonic developmental processes. The primary objective of this funding opportunity is to ensure the ongoing operation, maintenance, and enhancement of unique database resources that are crucial for biomedical research utilizing animal models, while promoting user training, data curation, and interoperability with other NIH bioinformatics tools. This initiative is significant for advancing research in the field and adheres to FAIR data principles, with funding amounts ranging from $500,000 to $1,750,000 annually for a maximum project period of five years. Interested applicants should note that the application submission deadlines begin on December 25, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy" under the R21 grant mechanism. This initiative aims to support the development and clinical validation of innovative, non-invasive methods to assess placental health throughout pregnancy, addressing critical issues such as preeclampsia and fetal growth restrictions. The funding, capped at $275,000 over a two-year period, is open to a diverse range of eligible applicants, including higher education institutions, nonprofit organizations, and tribal governments, with a submission deadline of November 16, 2024. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy" under the R01 grant mechanism, which does not allow clinical trials. This initiative aims to support the development and clinical validation of innovative, non-invasive methods to assess placental health throughout pregnancy, addressing critical issues such as preeclampsia and stillbirth. The funding is part of the Human Placenta Project and encourages applications from a diverse range of organizations, including educational institutions and community-based organizations, with no budget limits specified, although proposals should reflect actual project needs. Interested applicants must submit their proposals by November 5, 2024, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the largest longitudinal study of child health in the United States. This initiative, titled NIH Brain Development Cohorts (NBDC) Biospecimen Access, allows researchers to utilize biological samples such as blood, saliva, and hair to investigate the effects of environmental and biological factors on adolescent brain development and health. The program does not provide direct funding for research costs; applicants must secure their own funding and can apply for specific samples to enhance scientific understanding of adolescent health over a maximum project period of three years. Interested applicants can find more information and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov, with applications due by May 5, 2026.
    NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for Research Education Programs (R25), aimed at enhancing training for the biomedical, behavioral, and clinical research workforce. This grant supports innovative educational activities focused on research skills development, with a funding ceiling of $150,000 per year for a maximum of five years, and is not intended for clinical trials. The initiative emphasizes the importance of creating accessible educational opportunities that foster diversity and collaboration among participants, ranging from upper undergraduates to faculty. Interested applicants can find more information and application guidelines at the provided link, with proposals due by May 25, 2025, and inquiries directed to grantsinfo@nih.gov.